Gene · 4837
Papers1,489
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,489
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Large-scale analysis of cell-cell communication reveals angiogenin-dependent tumor progression in clear cell renal cell carcinoma. | iScience | 2023 | 38025776 | PubTator, text mining | PubMed |
| NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease. | Nat Commun | 2023 | 38016950 | PubTator, text mining | PubMed |
| Prognostic significance and immunoinfiltration analysis of genes associated with epithelial-mesenchymal transition and energy metabolism in bladder urothelial carcinoma. | Aging (Albany NY) | 2023 | 38015710 | PubTator, text mining | PubMed |
| Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment. | Molecules | 2023 | 38005235 | PubTator, text mining | PubMed |
Endocervical Adenocarcinoma Showing Microcystic, Elongated, and Fragmented (MELF) Pattern of Stromal Invasion: A Single-Institutional Analysis of 10 Cases with Comprehensive Clinicopathological Analyses and Ki-67 Immunostaining. | Biomedicines | 2023 | 38002025 | PubTator, text mining | PubMed |
| From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention. | Cancers (Basel) | 2023 | 38001718 | PubTator, text mining | PubMed |
| Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review. | Curr Oncol | 2023 | 37999111 | PubTator, text mining | PubMed |
| Genetic Discovery Enabled by A Large Language Model. | bioRxiv | 2023 | 37986848 | PubTator, text mining | PubMed |
| Biomarkers in renal cell carcinoma and their targeted therapies: a review. | Explor Target Antitumor Ther | 2023 | 37970211 | PubTator, text mining | PubMed |
| A polyamine metabolism risk signature for predicting the prognosis and immune therapeutic response of kidney cancer. | Transl Cancer Res | 2023 | 37969387 | PubTator, text mining | PubMed |
| Characterisation of Aberrant Metabolic Pathways in Hepatoblastoma Using Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS). | Cancers (Basel) | 2023 | 37958356 | PubTator, text mining | PubMed |
| Amnion responses to intrauterine inflammation and effects of inhibition of TNF signaling in preterm Rhesus macaque. | iScience | 2023 | 37953944 | PubTator, text mining | PubMed |
| Identification of biomarkers associated with immune-propionate metabolism in nonalcoholic fatty liver disease. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37953553 | PubTator, text mining | PubMed |
| Beyond the Rhythm: In Silico Identification of Key Genes and Therapeutic Targets in Atrial Fibrillation. | Biomedicines | 2023 | 37893006 | PubTator, text mining | PubMed |
| Metabolic sinkholes: Histones as methyl repositories. | PLoS Biol | 2023 | 37889915 | PubTator, text mining | PubMed |
| Lipid reprogramming induced by the NNMT-ABCA1 axis enhanced membrane fluidity to promote endometrial cancer progression. | Aging (Albany NY) | 2023 | 37889548 | PubTator, text mining | PubMed |
| A SIRT6 Inhibitor, Marine-Derived Pyrrole-Pyridinimidazole Derivative 8a, Suppresses Angiogenesis. | Mar Drugs | 2023 | 37888452 | PubTator, text mining | PubMed |
| Histone methyltransferase activity affects metabolism in human cells independently of transcriptional regulation. | PLoS Biol | 2023 | 37883365 | PubTator, text mining | PubMed |
| Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth. | Nat Commun | 2023 | 37880212 | PubTator, text mining | PubMed |
| Gene Expression Within a Human Choroidal Neovascular Membrane Using Spatial Transcriptomics. | Invest Ophthalmol Vis Sci | 2023 | 37878301 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4837/papers?page=11